Brenda Hoffman, MD
Gastroenterology · Charleston, SCNPI 1932217981
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,625 of the $6,942 with a category attached, or 66.6%. 6 manufacturers reported payments, led by Wilson Cook Medical Incorporated at 57.6% of the total. Reporting peaked in 2019 at $6,625 and has fallen 98.9% since, to $71 in 2025.
Across 8 payments — averaging $867.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Wilson Cook Medical Incorporated$4K
- Boston Scientific$3K
- Janssen Scientific Affairs, LLC$129
- AbbVie$97
- Johnson & Johnson$51
- Medtronic$39
Across 87 payments — averaging $4897.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$405K
- Takeda Pharmaceuticals U.S.A., Inc.$16K
- Pentax Of America, Inc.$6K
What the payments were for
- Speaking & faculty fees$4,62567%
- Food & beverage$3175%
- Education$2,00029%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Wilson Cook Medical Incorporated | 2 | $4,000 |
| Boston Scientific | 1 | $2,625 |
| Janssen Scientific Affairs, LLC | 1 | $129 |
| AbbVie | 1 | $97 |
| Johnson & Johnson | 1 | $51 |
| Medtronic | 2 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cook Medical Hemostasis$4,000
- CAPTIVATOR$2,625
- STELARA$129
How this compares
$6,942 in reported general payments places this provider in the 70th percentile of 259 gastroenterology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 95 | $1,684 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 94 | $1,612 |
| Omeprazole | 25 | $729 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 31 | $673 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Charleston
- Erin ForsterCharleston$788K
- Mark DeleggeCharleston$568K
- Nathan ShoresCharleston$217K
- Alejandro SuarezCharleston$210K
- Peter CottonCharleston$193K
- David KochCharleston$48K
- Derek FeussnerCharleston$35K
- Darin DufaultCharleston$33K
- John LitchfieldCharleston$23K
- James SchnellCharleston$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.